INVEST in FibroBiologics – Our Reg CF Offering is Now Open!

FOR SCIENTISTS ONLY: New articles added frequently.

The Science of Fibroblasts

News

Press Releases

FibroBiologics has released its annual report Form C-AR

FibroBiologics has released its annual report Form C-AR for the year ended December 31, 2022 – FibroBiologics is a clinical-stage cell therapy company focused on developing and commercializing fibroblast cell-based and fibroblast cell-derived product candidates as therapeutics for patients suffering from chronic diseases with significant unmet medical needs.

Read More »

Media

August 31, 2022

BioProcess Online

August 31, 2022

BioProcess Online

Access peer-reviewed articles and get accurate, relevant news about FibroBiologics